Science news articles about 'peregrine pharmaceuticals inc'

Peregrine Pharmaceuticals, Inc. (NASDAQ: PPHM) today reported publication of data in Nature Medicine that supports the broad anti-viral potential of the company's novel anti ...

... Calif., April 21, 2009--Peregrine Pharmaceuticals, Inc. (Nasdaq: PPHM), a clinical stage ... through internal efforts and collaborations with partners." About Peregrine's Clinical Stage Anti-PS Antibody ...